Definition & Risk Scores - The Unyielding Fever
-
IVIG Resistance: Defined as persistent or recrudescent fever (≥38°C) lasting for ≥36 hours after the completion of the initial IVIG infusion. This affects up to 20% of Kawasaki disease patients.
-
Key Laboratory Predictors for Resistance:
- ↑ C-reactive protein (CRP) >8 mg/dL
- ↑ Neutrophil count >80%
- ↓ Serum albumin <3.5 g/dL
- ↓ Sodium <135 mEq/L
- ↑ Alanine transaminase (ALT)
-
Clinical Risk Scoring Systems:
| Parameter | Kobayashi Score (≥5 pts) | Egami Score (≥3 pts) |
|---|---|---|
| Age | ≤12 months (1 pt) | ≤6 months (1 pt) |
| Sodium | ≤133 mEq/L (2 pts) | - |
| AST | ≥100 IU/L (2 pts) | - |
| Platelets | ≤30.0 x10⁴/μL (1 pt) | - |
| CRP | ≥10 mg/dL (1 pt) | ≥8 mg/dL (1 pt) |
| Neutrophils | ≥80% (2 pts) | - |
| Albumin | - | ≤3.5 g/dL (1 pt) |
Treatment Algorithm - Plan B Protocols
Management of patients who remain febrile ≥ 36 hours after the initial IVIG infusion.
⭐ Patients with IVIG-resistant Kawasaki disease have a significantly higher risk (up to 25%) of developing coronary artery aneurysms compared to responders.
Complications & Monitoring - The Artery Attack
IVIG resistance significantly ↑ risk of Coronary Artery Aneurysms (CAA), the hallmark complication.
- Risk Profile:
- Untreated: ~25% develop CAA.
- IVIG-Treated: Risk ↓ to <5%.
- IVIG-Resistant: Risk is substantially higher, mandating aggressive follow-up.
- Monitoring:
- Intensified surveillance with serial echocardiography is crucial to track coronary artery dimensions and function.
- Other Complications:
- Myocarditis
- Macrophage Activation Syndrome (MAS)
⭐ Most coronary artery changes develop within the first 4 weeks after fever onset. Early detection is key.

High‑Yield Points - ⚡ Biggest Takeaways
- IVIG resistance is defined as persistent or recrudescent fever ≥36 hours after completing the initial IVIG infusion.
- It is the strongest predictor for the development of coronary artery aneurysms (CAA).
- High-risk patients can be identified by scoring systems like the Kobayashi score.
- The standard second-line treatment is another dose of IVIG (2 g/kg).
- For refractory cases, treatment options include corticosteroids (prednisolone) or infliximab.
Unlock the full lesson and continue reading
Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more